Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v5-EN Version v3-EN
Language English English
Date Updated 2024-02-15 2024-02-14
Drug Identification Number 02241677 02241677
Brand name POTASSIUM CHLORIDE INJECTION POTASSIUM CHLORIDE INJECTION
Common or Proper name 20 mmol Potassium Chloride in 100 mL Sterile Water for Injection 20 mmol Potassium Chloride in 100 mL Sterile Water for Injection
Company Name BAXTER CORPORATION BAXTER CORPORATION
Ingredients POTASSIUM CHLORIDE POTASSIUM CHLORIDE
Strength(s) 20mEq 20mEq
Dosage form(s) SOLUTION LIQUID SOLUTION LIQUID
Route of administration INTRAVENOUS INTRAVENOUS INTRAVENOUS INTRAVENOUS
Packaging size 100 mL (JB0827P) 100 mL (JB0827P)
ATC code B05XA B05XA
ATC description I.V. SOLUTION ADDITIVES I.V. SOLUTION ADDITIVES
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2024-01-26 2024-01-26
Actual start date 2024-01-26 2024-01-26
Estimated end date 2024-02-14 2024-02-14
Actual end date 2024-02-14 2024-02-14
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments